An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer

Nir Peled,1 Vered Fuchs,2 Emily H Kestenbaum,2 Elron Oscar,2 Raul Bitran3 1Shaare Zedek Medical Center, The Hebrew University, Jerusalem, Israel; 2Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; 3The Legacy Heritage Oncology Center & Dr. Larry Norton Institute...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Peled N, Fuchs V, Kestenbaum EH, Oscar E, Bitran R
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2021
Materias:	lung cancer - volatile organic compounds (voc) – electronic nose (e-nose) – gc-ms - biomarkers Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/0cc58f5d10604d208540a9f5f91321be
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0cc58f5d10604d208540a9f5f91321be
record_format	dspace
spelling	oai:doaj.org-article:0cc58f5d10604d208540a9f5f91321be2021-12-02T18:01:14ZAn Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer1179-2728https://doaj.org/article/0cc58f5d10604d208540a9f5f91321be2021-08-01T00:00:00Zhttps://www.dovepress.com/an-update-on-the-use-of-exhaled-breath-analysis-for-the-early-detectio-peer-reviewed-fulltext-article-LCTThttps://doaj.org/toc/1179-2728Nir Peled,1 Vered Fuchs,2 Emily H Kestenbaum,2 Elron Oscar,2 Raul Bitran3 1Shaare Zedek Medical Center, The Hebrew University, Jerusalem, Israel; 2Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; 3The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva, IsraelCorrespondence: Nir PeledShaare Zedek Medical Center, 12, Shmuel Beit St, Jerusalem, 9103102, IsraelTel +972 587040620Email nirp@szmc.org.ilAbstract: Lung cancer has historically been the main responsible for cancer associated deaths. Owing to this is our current inability to screen for and diagnose early pathological findings, preventing us from a timely intervention when cure is still achievable. Over the last decade, together with the extraordinary progress in therapeutical alternatives in the field, there has been an ongoing search for a biomarker that would allow for this. Numerous technologies have been developed but their clinical application is yet to come. In this review, we provide an update on volatile organic compounds, a non-invasive method that can hold the key for detecting early metabolic pathway changes in carcinogenesis. For its compilation, web-based search engines of scientific literature such as PubMed were explored and reviewed, using articles, research, and papers deemed meaningful by authors discretion. After a brief description, we depict how this technique can complement current methods and present the value of electronic noses in the identification of the “breathprint”. Lastly, we bring some of the latest updates in the field together with the current limitations and final remarks.Keywords: lung cancer, volatile organic compounds, VOC, electronic nose, E-nose, GC-MS, biomarkersPeled NFuchs VKestenbaum EHOscar EBitran RDove Medical Pressarticlelung cancer - volatile organic compounds (voc) – electronic nose (e-nose) – gc-ms - biomarkersNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENLung Cancer: Targets and Therapy, Vol Volume 12, Pp 81-92 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	lung cancer - volatile organic compounds (voc) – electronic nose (e-nose) – gc-ms - biomarkers Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
spellingShingle	lung cancer - volatile organic compounds (voc) – electronic nose (e-nose) – gc-ms - biomarkers Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 Peled N Fuchs V Kestenbaum EH Oscar E Bitran R An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer
description	Nir Peled,1 Vered Fuchs,2 Emily H Kestenbaum,2 Elron Oscar,2 Raul Bitran3 1Shaare Zedek Medical Center, The Hebrew University, Jerusalem, Israel; 2Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; 3The Legacy Heritage Oncology Center & Dr. Larry Norton Institute, Soroka Medical Center, Beer-Sheva, IsraelCorrespondence: Nir PeledShaare Zedek Medical Center, 12, Shmuel Beit St, Jerusalem, 9103102, IsraelTel +972 587040620Email nirp@szmc.org.ilAbstract: Lung cancer has historically been the main responsible for cancer associated deaths. Owing to this is our current inability to screen for and diagnose early pathological findings, preventing us from a timely intervention when cure is still achievable. Over the last decade, together with the extraordinary progress in therapeutical alternatives in the field, there has been an ongoing search for a biomarker that would allow for this. Numerous technologies have been developed but their clinical application is yet to come. In this review, we provide an update on volatile organic compounds, a non-invasive method that can hold the key for detecting early metabolic pathway changes in carcinogenesis. For its compilation, web-based search engines of scientific literature such as PubMed were explored and reviewed, using articles, research, and papers deemed meaningful by authors discretion. After a brief description, we depict how this technique can complement current methods and present the value of electronic noses in the identification of the “breathprint”. Lastly, we bring some of the latest updates in the field together with the current limitations and final remarks.Keywords: lung cancer, volatile organic compounds, VOC, electronic nose, E-nose, GC-MS, biomarkers
format	article
author	Peled N Fuchs V Kestenbaum EH Oscar E Bitran R
author_facet	Peled N Fuchs V Kestenbaum EH Oscar E Bitran R
author_sort	Peled N
title	An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer
title_short	An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer
title_full	An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer
title_fullStr	An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer
title_full_unstemmed	An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer
title_sort	update on the use of exhaled breath analysis for the early detection of lung cancer
publisher	Dove Medical Press
publishDate	2021
url	https://doaj.org/article/0cc58f5d10604d208540a9f5f91321be
work_keys_str_mv	AT peledn anupdateontheuseofexhaledbreathanalysisfortheearlydetectionoflungcancer AT fuchsv anupdateontheuseofexhaledbreathanalysisfortheearlydetectionoflungcancer AT kestenbaumeh anupdateontheuseofexhaledbreathanalysisfortheearlydetectionoflungcancer AT oscare anupdateontheuseofexhaledbreathanalysisfortheearlydetectionoflungcancer AT bitranr anupdateontheuseofexhaledbreathanalysisfortheearlydetectionoflungcancer AT peledn updateontheuseofexhaledbreathanalysisfortheearlydetectionoflungcancer AT fuchsv updateontheuseofexhaledbreathanalysisfortheearlydetectionoflungcancer AT kestenbaumeh updateontheuseofexhaledbreathanalysisfortheearlydetectionoflungcancer AT oscare updateontheuseofexhaledbreathanalysisfortheearlydetectionoflungcancer AT bitranr updateontheuseofexhaledbreathanalysisfortheearlydetectionoflungcancer
_version_	1718378969389072384

An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer

Ejemplares similares